{
  "id": 15512662,
  "title": "Viking Therapeutics Just Raised $575 Million. Here's What It Means for the Obesity Stock's Next Chapter.",
  "url": "https://urgent.news/2026/10/18/viking-therapeutics-just-raised-575-million-heres-what-it-means-for-15512662",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-18T22:50:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/viking-therapeutics-just-raised-575-million-heres-what-it-means-obesity-stocks-next"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsMultiple phase 3 trials for VK2735 are ongoing, with key results expected in 2027 to 2028.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Viking Therapeutics Just Raised $575 Million. Here's What It Means for the Obesity Stock's Next Chapter.",
        "url": "https://urgent.news/2026/10/18/viking-therapeutics-just-raised-575-million-heres-what-it-means-for",
        "published": "2026-10-18T22:30:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}